6th December 2009 SEOUL, Korea, RNL Bio Co., Ltd, a leading biopharmaceutical company specialized in adult stem cell therapeutics (a Stem Cell Bank as they call themselves) has announced that a 46-year-old female, Kang Sook Park’s Multiple Sclerosis improved tremendously after receiving stem cell treatment. Ms. Park was suffering from MS (Multiple Sclerosis), an autoimmune disease that affects the central nervous system (brain and spinal cord).
For the past 20 years, Park suffered from MS. For stem cell injection, she was admitted into Choyang Hospital of Regenerative Medicine in Yanji, China for three weeks. She received stem cells intravenously as well as intrathecally. The injections were given in five intervals — a total of 1.2 billion cells.
Prior to stem cell treatment, Park suffered from Optic Neuritis — a common symptom of MS. Some of the symptoms of Optic Neuritis include double vision, vision loss, and uncontrollable rapid eye movements. She was not able to recognize any writing due to her vision loss. After six months of receiving stem cell therapy, Park experienced phenomenal changes. Her vision improved drastically — she was able to read. Furthermore, it also became possible for her to move her legs using her own muscular strength.
“My legs felt like hollow logs. They were so numb and stiff. However, after receiving stem cell treatment, I can actually feel my legs. I can also tell the difference in cold and warm temperatures. Stem cell therapy brought incredible changes to my physical condition,” stated Kang Sook Park.
Dr. Chang Won Kim reported Park’s EMG findings before and after the stem cell treatment. “Patients who have an uncommon disease such as MS rarely show improvement or are completely cured. EMG results showed that Park’s movement increased both in upper and lower limbs. Reduction in latency suggests that demyelination was also improved. It is extremely difficult for MS patients to use their own strength to even make small movements in the arms or legs. These changes in Park were possible through stem cell therapy.”
President and CEO of RNL Bio, Dr. Jeong Chan Ra expressed, “The effective outcomes from stem cell treatment for rare diseases like Multiple Sclerosis can be used in the future. I will do my best to help improve the quality of life for people who are suffering from diseases like MS.”